Stay updated on Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial page.

Latest updates to the Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial page
- Check2 days agoChange DetectedLocations updated: added Hôpital de l'Archet, Charité - Universitätsmedizin Berlin, and Queen Elizabeth Hospital; removed HOP l'Archet, Charité Universitätsmedizin Berlin KöR, and Queen Elizabeth Hospital-Kota Kinabalu-40735. An EU CTIS number (2023-509216-28-00) was added along with a data-sharing link.SummaryDifference0.3%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision: v3.5.0 is now displayed, replacing Revision: v3.4.3.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision v3.4.3 was added and revision v3.4.2 was removed.SummaryDifference0.0%

- Check38 days agoChange DetectedAdded a Generalized pustular psoriasis entry and a new Resources link to the Genetic and Rare Diseases Information Center.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision banner updated from v3.4.1 to v3.4.2, reflecting an internal software update.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Spesolimab Long-Term in Generalized Pustular Psoriasis Clinical Trial page.